The Denmark Herald
SEE OTHER BRANDS

The top news stories from Denmark

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on The Denmark Herald.

Zealand Pharma Announces Financial Results for the First Half of 2025

Zealand Pharma Announces Financial Results for the First Half of 2025

Company announcement – No. 18 / 2025 Zealand Pharma Announces Financial Results for the First Half of 2025 Petrelintide collaboration with Roche off to a strong start, while key leadership appointments and solid financial position enable exciting...

Defence export success for SA missile manufacturer

Defence export success for SA missile manufacturer

Release date: 14/08/25 Two major export deals worth a combined $80 million have been secured by Kongsberg Defence Australia, seeing missile launchers and command and control consoles made in South Australia soon to be exported to Europe. Last...

Israel threatens to ban major aid organizations as starvation deepens

Israel threatens to ban major aid organizations as starvation deepens

Unless INGOs submit to the full registration requirements, including the mandatory submission of details of private donors, complete Palestinian staff lists and other sensitive information about personnel for so-called “security” vetting to...

TPI Composites, Inc. Advances Chapter 11 Process with Court Approval of First-Day Motions

TPI Composites, Inc. Advances Chapter 11 Process with Court Approval of First-Day Motions

Secures Access to Liquidity and Financial Flexibility Operations Continue Uninterrupted for Employees, Customers, and Supply Partners Company Focused on Executing Strategic Initiatives for Long-Term Stability SCOTTSDALE, Ariz., Aug. 13, 2025...

Russian attack murders many foreign fighters in Ukraine

Russian attack murders many foreign fighters in Ukraine

(MENAFN) A Russian strike in late July inflicted heavy casualties on foreign mercenaries in Ukraine by targeting a training camp run by Ukrainian military intelligence, the New York Times reported on Tuesday. The attack, which occurred on July 21...

Personalized Retail Nutrition and Wellness Market to Drive USD 16.25 Billion by 2034

Personalized Retail Nutrition and Wellness Market to Drive USD 16.25 Billion by 2034

Ottawa, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Towards Healthcare, a sister firm of Precedence Research, reports that the global personalized retail nutrition and wellness market size was valued at USD 3.94 billion in 2024 and is projected to reach...

Halal Food and Beverage Market Size Worth USD 5.44 Trillion by 2034, Fueled by 8% CAGR and Rising Global Demand

Halal Food and Beverage Market Size Worth USD 5.44 Trillion by 2034, Fueled by 8% CAGR and Rising Global Demand

Ottawa, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The global halal food and beverage market size accounted for USD 2.52 trillion in 2024 and is predicted to rise form USD 2.72 trillion in 2025 to around USD 5.44 trillion by 2034, expanding at a CAGR of 8%...

Vegan Beverages Market Size Set to Reach USD 61.89 Billion by 2034, Driven by Health and Sustainability

Vegan Beverages Market Size Set to Reach USD 61.89 Billion by 2034, Driven by Health and Sustainability

Ottawa, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The global vegan beverages market size was valued at USD 19.06 billion in 2024 with projections indicating a rise from USD 21.44 billion in 2025 to reach nearly USD 61.89 billion by 2034, growing at a CAGR...

Russian attack murders foreign mercenaries in Ukraine

Russian attack murders foreign mercenaries in Ukraine

(MENAFN) A Russian attack in late July significantly impacted foreign mercenaries in Ukraine when it struck a training camp operated by Ukrainian military intelligence, according to reports. The strike hit the camp near the central city of...

Global-e Reports Second Quarter 2025 Results

Global-e Reports Second Quarter 2025 Results

PETAH-TIKVA, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE) the platform powering global direct-to-consumer e-commerce, today reported financial results for the second quarter of 2025. “We had another strong quarter,...

Opoint Appoints Peter Ferrold as New CEO

Opoint Appoints Peter Ferrold as New CEO

COPENHAGEN, DENMARK, August 4, 2025 /⁨EINPresswire.com⁩/ -- Opoint is pleased to announce the appointment of Peter Ferrold as its new Chief Executive Officer, effective August 11, 2025. Based in Copenhagen, Peter will lead Opoint into its next...

Joint statement on behalf of 29 partners on aid to Gaza and restrictions facing NGOs

Joint statement on behalf of 29 partners on aid to Gaza and restrictions facing NGOs

SLOVENIA, August 12 - However, due to restrictive new registration requirements, essential international NGOs may be forced to leave the OPTs imminently which would worsen the humanitarian situation still further. We call on the government of...

Research-Grade Proteins Market to Expand at 15.57% CAGR by 2034

Research-Grade Proteins Market to Expand at 15.57% CAGR by 2034

Ottawa, Aug. 12, 2025 (GLOBE NEWSWIRE) -- According to a study published by Towards Healthcare, a sister firm of Precedence Research, the global research-grade proteins market size will grow from USD 1.13 billion in 2024 to around USD 4.81 billion...

In Vitro Diagnostics Market Size to Exceed USD 132.18 Bn by 2034

In Vitro Diagnostics Market Size to Exceed USD 132.18 Bn by 2034

Ottawa, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The worldwide in vitro diagnostics market size accounted for USD 102.05 billion in 2024, and is predicted to grow from USD 104.01 billion in 2025 to approximately USD 132.07 billion by 2034. The growing...

Human Blood Products Market to Reach USD 76.36 Billion by 2034, Says Towards Healthcare Research

Human Blood Products Market to Reach USD 76.36 Billion by 2034, Says Towards Healthcare Research

Ottawa, Aug. 12, 2025 (GLOBE NEWSWIRE) -- According to a study published by Towards Healthcare, a sister firm of Precedence Research, the global human blood products market size stood at USD 45.82 billion in 2024 and is expected to surge...

Circular Packaging Market to Reach USD 469.28 Billion by 2034, Growing from USD 266.25 Billion at a CAGR of 6.5%

Circular Packaging Market to Reach USD 469.28 Billion by 2034, Growing from USD 266.25 Billion at a CAGR of 6.5%

Ottawa, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The global circular packaging market size stood at USD 266.25 billion in 2025 and is projected to reach USD 469.28 billion by 2034, according to a study published by Towards Packaging, a sister firm of...

LiqTech to Discuss Second Quarter 2025 Results on Wednesday, August 13, 2025

LiqTech to Discuss Second Quarter 2025 Results on Wednesday, August 13, 2025

BALLERUP, Denmark, Aug. 07, 2025 (GLOBE NEWSWIRE) -- LiqTech International, Inc. (NASDAQ: LIQT), a high-tech filtration company that manufactures and markets highly specialized filtration products and systems, will report second quarter 2025...

Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results

Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results

Press Release – No. 11 / 2025 Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results Copenhagen, Denmark, August 7, 2025 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a...

Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL)

Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL)

Company Announcement COPENHAGEN, Denmark; August 7, 2025 Epcoritamab in combination with rituximab and lenalidomide (R2) demonstrated statistically significant improvement in Overall Response Rate (ORR; 95.7%, p < 0.0001) and Progression-Free...

Genmab Announces Financial Results for the First Half of 2025

Genmab Announces Financial Results for the First Half of 2025

August 7, 2025 Copenhagen, Denmark; Interim Report for the First Half Ended June 30, 2025 Highlights Epcoritamab advancing to earlier lines of therapy with the submission of a sBLA to the FDA for epcoritamab plus R2 in patients with relapsed or...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions